Skip to main content
Caplight Logo









Clear.bio

Clear.bio

Private
AmsterdamHealthcare & Life Scienceshttps://www.clear.bio/

Last Round

VC Round

Sep 29, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Clear.bio is a healthtech company that provides a digital therapeutics platform with personalized nutrition plans to help users manage and reverse type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Telemedicine, Patient Engagement, Health IoT, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

digital therapeuticscontinuous glucose monitoringCGMdiabetes managementtype 2 diabetespersonalized nutritionremote patient monitoringDTxAI health coachdigital healthmedical device platformlifestyle interventiondiabetes reversalhealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clear.bio Comparables

Compare Clear.bio with similar companies based on industry and business-model similarity.

Clear.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Una Health
81%
DexCom
81%
Signos
75%

Clear.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 29, 2025
VC RoundNov 9, 2022
VC RoundMar 10, 2022
VC RoundNov 3, 2021
AcceleratorNov 1, 2019

Key People

Founding team and executive leadership

Piet Hein van Dam

CEO and founder

Founding Team

Parul Vats

Chief Technology Officer

Executive Team

Clear.bio Investors

Notable investors and investment history

Clear.bio investors
InvestorRounds
Horizon FlevolandVC Round
Mustard Seed MazeVC Round
Future Food FundVC Round
AntlerVC Round, Accelerator
Invest InternationalVC Round
Future Food FundVC Round
AchmeaVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 29, 2025

    $1.84M round raised.

  • Mar 30, 2025

    Added Cliquemedia, a digital media SMB, as a customer.

Clear.bio Filings

Explore SEC and related filing metadata, where available.

Clear.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Clear.bio's valuation, stock price, and market status.

Is Clear.bio a public or private company?

Clear.bio is a private company.

What is the current stock price of Clear.bio?

Clear.bio is a private company with no public stock price. No recent secondary market data is available.

How much is Clear.bio worth (valuation)?

Valuation information for Clear.bio is not publicly available.

Can I buy Clear.bio stock?

Clear.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Clear.bio's last funding round?

Clear.bio's most recent funding round was VC Round on September 25, 2025.

Who are the main investors in Clear.bio?

Key investors in Clear.bio include Mustard Seed Maze, Achmea, Healthy.Capital.

Will Clear.bio IPO soon?

No public IPO plans have been announced for Clear.bio.

How can I track Clear.bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clear.bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range16
Year Founded2019
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?